Orion research foundation grants €1 million for research
Orion and Finland are both celebrating their centenaries in 2017.
List view / Grid view
Orion and Finland are both celebrating their centenaries in 2017.
Cancer Research UK announced that four international teams are the first recipients of its global £100m Grand Challenge competition, which aims to overcome the biggest challenges facing cancer researchers in a global effort to beat cancer sooner.
The biotechnology company Genmab announced today the appointment of Judith Klimovsky, MD, as Executive Vice President and Chief Development Officer.
Organ models, which are cultivated in the laboratory from human stem cells and grow into living tissue, are one of the most important scientific breakthroughs of recent years.
The designation certifies that Exco InTouch’s practices meet or exceed the data privacy and security principles outlined by US Department of Commerce and European Commission.
Pharma companies involved include Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis, and Pfizer.
The transaction has been approved unanimously by the boards of directors of both companies, and is expected to close by the end of February 2017.
FDA Present on Regulatory Considerations for Combination Products at Pre-Filled Syringes East Coast this Spring...
Macrophage Pharma, a newly formed immune-oncology company, has successfully raised £9 million in a Series A equity financing round.
This award recognises outstanding achievements of female researchers in the life sciences in the past five years.
The monoclonal antibody biopharmaceutical group Kymab announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.
Enterome is pleased to announce the appointments of Jai Patel, PhD as Chief Medical Officer and Roger Garceau, MD as non-executive Director.
1 December 2016 | By Niamh Louise Marriott, Digital Editor
The funds will enable Kymab to advance its proprietary pipeline of first-in-class therapeutic human monoclonal antibodies, with clinical development in 2017...
29 November 2016 | By Niamh Louise Marriott, Digital Editor
The Research Training Groups will receive funding of around €87 million for an initial period of four and a half years...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at the University of Oxford have been working with two major EU-funded projects to deliver a novel antibiotic programme for clinical development...